Biostar Pharmaceuticals Inc (BSPM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,454 | -2,329 | -1,014 | -5,698 | -9,087 |
| Depreciation Amortization | 880 | 580 | 298 | 1,143 | 913 |
| Income taxes - deferred | N/A | N/A | N/A | 2,653 | N/A |
| Accounts receivable | 6,879 | 6,810 | 1,238 | 8,670 | 1,605 |
| Other Working Capital | 6,449 | 6,612 | 1,054 | 7,308 | 1,310 |
| Other Operating Activity | -7,169 | -7,086 | -1,255 | -9,163 | 6,169 |
| Operating Cash Flow | $4,586 | $4,587 | $321 | $4,913 | $911 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -4,408 | -4,364 | 0 | -6,378 | 0 |
| Investing Cash Flow | $-4,408 | $-4,364 | $N/A | $-6,378 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 1,690 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -278 | -281 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $1,411 | $-281 |
| Exchange Rate Effect | 14 | 11 | -11 | 189 | -10 |
| Beginning Cash Position | 173 | 173 | 173 | 39 | 39 |
| End Cash Position | 365 | 407 | 484 | 173 | 659 |
| Net Cash Flow | $192 | $234 | $311 | $134 | $621 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,586 | 4,587 | 321 | 4,913 | 911 |
| Free Cash Flow | 4,586 | 4,587 | 321 | 4,913 | 911 |